Finance Home - My Yahoo - Yahoo! - Help

Saturday, December 26, 2009, 7:40AM ET - U.S. Markets Closed. Dow  0.51% Nasdaq  0.71%

Opexa Therapeutics, Inc. (OPXA)

On Dec 24: 1.98   0.01 (0.50%)

MORE ON OPXA

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Competitors Get Competitors for:
DIRECT COMPETITOR COMPARISON   OPXA Pvt1 SNY TEVA Industry Market Cap: 25.56M N/A 104.11B 49.28B 104.49M Employ­ees: 10 38,0001 98,213 38,307 63 Qtrly Rev Growth (yoy): N/A N/A 8.50% 24.90% 19.10% Revenue (ttm): N/A 15.09B1 N/A 12.95B 13.84M Gross Margin (ttm): N/A N/A 75.20% 55.30% 65.67% EBITDA (ttm): -5.05M N/A N/A 3.94B -11.86M Oper Margins (ttm): N/A N/A N/A 24.35% -149.46% Net Income (ttm): -2.27M N/A N/A 953.00M N/A EPS (ttm): -0.184 N/A N/A 1.093 -0.31 P/E (ttm): N/A N/A N/A 51.18 17.48 PEG (5 yr expected): N/A N/A 2.5 1.12 1.35 P/S (ttm): N/A N/A N/A 3.81 10.13 Pvt1 = Bayer Schering Pharma AG (privately held) SNY = Sanofi-Aventis TEVA = Teva Pharmaceutical Industries Limited Industry = Biotechnology 1 = As of 2008   BIOTECHNOLOGY COMPANIES RANKED BY SALES   Company Symbol Price Change Market Cap P/E Amgen Inc. AMGN 57.42 0.12% 58.12B 12.52 Genentech, Inc. Private - View Profile Biogen Idec Inc. BIIB 52.24 0.15% 15.11B 17.48 Genzyme Corp. GENZ 48.50 0.62% 12.87B 27.65 Merck Serono S.A. Private - View Profile Chiron Corporation Private - View Profile Gilead Sciences Inc. GILD 43.00 -0.02% 38.70B 16.63 MedImmune, Inc. Private - View Profile Life Technologies Corporation LIFE 52.17 0.68% 9.30B 1064.69 Teva Pharmaceutical Industries Limited TEVA 55.94 -0.07% 49.28B 51.18 View Biotechnology Industry Center GENERIC DRUGMAKERS RANKED BY SALES   Company Symbol Price Change Market Cap P/E Sandoz International GmbH Private - View Profile Watson Pharmaceuticals Inc. WPI 39.91 0.28% 4.24B 20.57 King Pharmaceuticals Inc. KG 12.14 -0.82% 3.01B N/A Ranbaxy Laboratories Limited Private - View Profile Mylan, Inc. MYL 18.74 0.00% 5.73B 114.97 Pfizer Inc. PFE 18.60 0.11% 150.09B 15.45 Johnson & Johnson JNJ 64.70 0.20% 178.51B 14.13 GlaxoSmithKline plc GSK 42.29 0.48% 107.21B 13.87 Sanofi-Aventis SNY 39.87 0.43% 104.11B N/A Novartis AG NVS 54.84 0.44% 124.55B 16.42 View Biotechnology Industry Center DRUGMAKERS RANKED BY SALES   Company Symbol Price Change Market Cap P/E RHHBY.PK 43.20 0.93% N/A N/A AstraZeneca plc AZN 46.38 0.89% 67.25B 9.31 Abbott Laboratories ABT 54.15 0.11% 83.76B 14.67 Bristol-Myers Squibb Co. BMY 25.76 0.23% 51.03B 13.33 View Biotechnology Industry Center NEWS ON DIRECT COMPETITORS   • SNY SEC: Men Made 'Illicit Profits' in Sanofi-Chattem Deal Thu, Dec 24 - at The Wall Street Journal Online • TEVA Teva joint venture buys stake in Japan drugmaker Thu, Dec 24 - AP • SNY Why Investing's Better in Bhutan Thu, Dec 24 - at Motley Fool • TEVA Israel Stocks: Israel stocks up; Teva gets lift; Givot finds oil Thu, Dec 24 - at MarketWatch • SNY European Health Care Approvals And Partnership With Drug Giant Novartis Cements This Stocks Rating As A Good Buy, According To Senior Portfolio Manager Thu, Dec 24 - Wall Street Transcript • TEVA Teva Deal a Reality Check for OncoGenex Investors Thu, Dec 24 - at Seeking Alpha • TEVA Five Fast-Growing Stocks to Own Thu, Dec 24 - at TheStreet.com • SNY Sanofi-Aventis Reaches over the Counter Thu, Dec 24 - at Seeking Alpha • TEVA Teva-Kowa to buy 2/3 of closely held Taisho Thu, Dec 24 - at MarketWatch • SNY Sanofi Pulls the Plug on Two Drugs: Biotech's Latest Mishaps Thu, Dec 24 - at Seeking Alpha • TEVA Teva-KOWA Pharma to Acquire a Majority Share Interest in Taisho Pharmaceutical Industries Thu, Dec 24 - Business Wire • SNY AZ and Forest tie up to buy Novexel Wed, Dec 23 - at FT.com • SNY SEC charges two men with insider trading in Sanofi-Chattem deal Wed, Dec 23 - at bizjournals.com • SNY FDA Licenses New Influenza Vaccine Designed Specifically for People 65 Years of Age and Older Wed, Dec 23 - PR Newswire All Headlines for these symbols... Need more? Get unbiased, in-depth information on public and private companies worldwide from Hoover's Online.
Add to Portfolio     Set Alert     Email to a Friend Get Competitors for Another Symbol: Symbol Lookup • Stock Screener • Sector Analysis